Delcath Archives - Cardiac Vascular News

Tag: Delcath

A Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting

Radiology September 11, 2023 by Ken Dropiewski 0 comments

NEW YORK, Sept. 11, 2023 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the details of an oral presentation by independent investigators on September 9, 2023 at the Cardiovascular and […]

Continue Reading →

Delcath Systems (DCTH) Announces Relisting On OTCQB

Financial Radiology September 13, 2017 by Ken Dropiewski 0 comments

NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) — Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that its Board of Directors has approved the voluntary delisting from NASDAQ. As […]

Continue Reading →

Tag: Delcath

A Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting

Delcath Systems (DCTH) Announces Relisting On OTCQB

Recent

New Data Demonstrates Vektor Medical’s AI-Powered vMap Algorithm Achieves 91% Accuracy in Distinguishing Epicardial and Endocardial Ventricular Tachycardia, Markedly Surpassing Visual ECG Analysis

Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025

Genomadix Inc. Enters into Collaboration with Mayo Clinic on Precision Medicine for Telestroke

Popular

Subscribe to Blog via Email